Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Folahan Ayoola

Surgery Denton, TX Medical Doctor

NPI 1851500201 CMS profile 357124

3321 Colorado Blvd, Denton, TX 76210

Open in the dashboard

General payments

$570,441

854 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Folahan Ayoola of Denton, TX is reported in the CMS Open Payments database as having received $570,441 across 854 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $30,060 66
2024 General $76,635 116
2023 General $146,683 193
2022 General $153,553 168
2021 General $133,060 169
2020 General $26,565 88
2019 General $3,885 54

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Folahan Ayoola
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Folahan Ayoola were reported at $30,060. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Folahan Ayoola Surgery median Middle half National median
2019 $3,885 $253 $82–$1,521 $163
2020 $26,565 $131 $40–$706 $114
2021 $133,060 $168 $50–$904 $132
2022 $153,553 $224 $76–$1,218 $149
2023 $146,683 $253 $82–$1,255 $160
2024 $76,635 $279 $90–$1,381 $164
2025 $30,060 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $547,849 654 payments
  2. Medical Device Business Services, Inc. $11,975 13 payments
  3. Ethicon US, LLC $2,238 68 payments
  4. Ethicon Inc. $1,950 1 payment
  5. CONMED Corporation $1,642 4 payments
  6. VIVUS, Inc. $1,090 27 payments
  7. Baxter Healthcare $816 16 payments
  8. KVK-Tech, Inc. $618 25 payments
  9. Medtronic, Inc. $573 6 payments
  10. W. L. Gore & Associates, Inc. $307 3 payments
  11. Other $1,382 37 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $370,200 132 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $103,000 63 payments
  3. Travel and Lodging $48,421 230 payments
  4. Food and Beverage $33,747 413 payments
  5. Consulting Fee $15,028 12 payments
  6. Gift $45 4 payments
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $491,999 629 payments
  2. DA VINCI SP $55,850 25 payments
  3. Echelon Flex Endo-Mechanical $7,925 8 payments
  4. ETHICON $3,360 12 payments
  5. VISTASEAL $2,606 37 payments
  6. ECHELON FLEX Stapler $1,097 7 payments
  7. QSYMIA $1,059 25 payments
  8. ECHELON ENDOPATH $926 9 payments
  9. Echelon Flex Surgery-Bariatric $780 1 payment
  10. TISSEEL $440 9 payments
  11. Other $4,576 124 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 18 billing codes

Paid by Medicare

$44,041

Medicare's payments for the services billed

Medicare patients

106

Average age 68

Services billed

329

80 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 67%
Depression 42%
Diabetes 31%
Chronic kidney disease 25%
Ischemic heart disease 20%
Osteoporosis 20%
Atrial fibrillation 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ZEPBOUND
  • Lilly USA, LLC $15
$15 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

854 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record